| 000 | 01686 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513091825.0 | ||
| 264 | 0 | _c19960903 | |
| 008 | 199609s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.271.30.17979 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPazhanisamy, S | |
| 245 | 0 | 0 |
_aKinetic characterization of human immunodeficiency virus type-1 protease-resistant variants. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cJul 1996 |
||
| 300 |
_a17979-85 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCarbamates |
| 650 | 0 | 4 | _aFurans |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 |
_aHIV Protease _xdrug effects |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHIV-1 _xenzymology |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 | _aIndinavir |
| 650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOligopeptides _xmetabolism |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aQuinolines _xpharmacology |
| 650 | 0 | 4 | _aSaquinavir |
| 650 | 0 | 4 | _aSelection, Genetic |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 700 | 1 | _aStuver, C M | |
| 700 | 1 | _aCullinan, A B | |
| 700 | 1 | _aMargolin, N | |
| 700 | 1 | _aRao, B G | |
| 700 | 1 | _aLivingston, D J | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 271 _gno. 30 _gp. 17979-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.271.30.17979 _zAvailable from publisher's website |
| 999 |
_c8662076 _d8662076 |
||